Effect of sodium valproate on serum amylase in epileptics.

dc.contributor.authorJha, Sen_US
dc.contributor.authorNag, Den_US
dc.contributor.authorShukla, Ren_US
dc.contributor.authorKar, A Men_US
dc.contributor.authorKumar, Aen_US
dc.date.accessioned1993-03-01en_US
dc.date.accessioned2009-05-31T11:46:26Z
dc.date.available1993-03-01en_US
dc.date.available2009-05-31T11:46:26Z
dc.date.issued1993-03-01en_US
dc.description.abstractThirty-eight patients of generalised tonic-clonic seizures of epileptics in the age group of 15-30 years were included in this study. Of these 20 were started sodium valproate afresh and 18 already taking it for more than one year prior to inclusion. Serum amylase and serum valproic acid levels were measured in all of them, initially and at every 3 months interval for 9 months. Though no clinical evidence was present, there was significant increase in serum amylase levels in both the groups which has no correlation with dose or serum valproic acid levels.en_US
dc.description.affiliationDepartment of Neurology, King George's Medical College, Lucknow.en_US
dc.identifier.citationJha S, Nag D, Shukla R, Kar AM, Kumar A. Effect of sodium valproate on serum amylase in epileptics. Journal of the Indian Medical Association. 1993 Mar; 91(3): 53-4en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/100510
dc.language.isoengen_US
dc.source.urihttps://www.jimaonline.org.in/en_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAmylases --blooden_US
dc.subject.meshEpilepsy, Tonic-Clonic --drug therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshTime Factorsen_US
dc.subject.meshValproic Acid --blooden_US
dc.titleEffect of sodium valproate on serum amylase in epileptics.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: